Over a 5-year period, the drug was well tolerated and...
Artículos Científicos en Ingles
Artículos Científicos RSS ASN
Artículos Científicos RSS AJKD
In Reply to ‘Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 Glomerulopathy’We agree with Duineveld et al1 that no definitive... | Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 GlomerulopathyBased on a retrospective evaluation of patients with C3 ... | Kidney TattoosDan and Matt have a great deal in common, although they... |


